Literature DB >> 2348837

Association of primary sclerosing cholangitis with HLA-DRw52a.

E J Prochazka1, P I Terasaki, M S Park, L I Goldstein, R W Busuttil.   

Abstract

We sought to determine whether there are specific HLA haplotypes in patients with either primary sclerosing cholangitis or primary biliary cirrhosis. Surprisingly, 100 percent of the 29 patients with primary sclerosing cholangitis had the HLA-DRw52a antigen, which is normally present in 35 percent of the population (relative risk, 109.5; P less than 0.00001). Fifteen of these patients had a single common haplotype: A1,B8,Cw7,DRw17,DQw2,DRw52a. In the remaining 17 patients there was a loss of at least one of these antigens. Of the 15 patients with the common haplotype, 12 also had ulcerative colitis, thereby linking the occurrence of ulcerative colitis in patients with primary sclerosing cholangitis to the presence of this haplotype. Although there was no association in 35 patients between primary biliary cirrhosis and specific HLA haplotypes, there was a significant association of the disease with DRw8 (relative risk, 3.1; P = 0.02). We conclude that the development of primary sclerosing cholangitis involves a strong genetic predisposition. Since the association of primary sclerosing cholangitis with HLA-DRw52a appears to be total, HLA typing should be helpful in differentiating this disease from primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348837     DOI: 10.1056/NEJM199006283222603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

3.  HLA antigens in primary sclerosing cholangitis.

Authors:  K Noguchi; M Kobayashi; A Yagihashi; Y Yoshida; K Terasawa; A Konno; F Ichida; M Venek; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 4.  Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature.

Authors:  Abdullah M S Al-Osaimi; Carl L Berg
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

5.  Analysis of complex genetic systems by ARMS-SSCP: application to HLA genotyping.

Authors:  Y M Lo; P Patel; W Z Mehal; K A Fleming; J I Bell; J S Wainscoat
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

Review 6.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

7.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.

Authors:  H Zetterquist; U Broomé; K Einarsson; O Olerup
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 9.  Genetic epidemiology of primary sclerosing cholangitis.

Authors:  Tom-H Karlsen; Erik Schrumpf; Kirsten-Muri Boberg
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 10.  Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?

Authors:  R W Chapman
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.